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TelemetryIn some patients, intracerebral hemorrhage (ICH) causes life-threatening elevations in intracranial pressure (ICP)
arising frommass effect of the hematoma and edema. Accordingly, edema is a common endpoint to gauge treat-
ment efﬁcacy in rodent ICHmodels. Despitewidespread reliance on edema, its relationshipwith ICP and cerebral
perfusion pressure (CPP) is unknown. Blood pressure (BP) and ICP were measured by telemetry devices in rats
after collagenase (“severe” — 0.3 U, and “moderate” — 0.15 U doses) or blood infusion (100 μL) into striatum
(vs. saline infused shams). We compared epidural and intraparenchymal ICP readings (collagenase), evaluated
CPP (collagenase), and comparedmodels. Moderate (9.46 mmHg± 4.72 SD, 3 day average) and severe collage-
nase ICHs (10.79± 3.50) signiﬁcantly increased ICP versus shams (4.02± 2.09), whereas blood infusion did not
(5.37± 0.55). The twomonitoring locations gave similar readings after severe collagenase ICH. Increased ICP re-
duced CPP by ~7.5 mmHg for days after the larger collagenase infusion. CPP averaged from 103–112 mm Hg in
shams. Edema occurred in all ICHmodels and predicted ICP. However, ICP and CPPwere only modestly changed
even after severe ICH and edema. Thus, small changes in edema typically reported in the literature, which often
use smaller bleeds than presently used, likelyminimally affects ICP and CPP. Further research into the face valid-
ity of these models, endpoints, and their ability to evaluate therapeutics is needed.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Intracerebral hemorrhage (ICH) is the second-most common
stroke with a high mortality and morbidity rate (Sacco et al., 2009).
The hematoma mass effect and progressive edema can lead to life-
threatening elevations in intracranial pressure (ICP) (Janny et al.,
1982; Venkatasubramanian et al., 2011). As ICP rises, compressed
peri-hematoma tissue can theoretically become ischemic (Bullock
et al., 1988), though some studies do not support this (Zazulia
et al., 2001). Cranial hypertension can lead to brain herniation and
reduced cerebral perfusion pressure (CPP = mean arterial pressure
(MAP)− ICP). The impact anti-edema therapies have on functional
outcome after ICH and the beneﬁt of ICP monitoring is debateable.
As neurological status also does not neatly correlate with ICP and
edema in ICH patients (Inaji et al., 2003; Papo et al., 1979), the im-
portance of ICP as an endpoint in clinical and animal ICH research
is not entirely clear. Furthermore, whether current ICH models
mimic clinical ICP changes is unknown.
The most common ICH models involve injecting blood or collage-
nase into the striatum of rodents (Kirkman et al., 2011; MacLellances Building Department of
Canada. Fax: +1 780 492 1768.
. This is an open access article underet al., 2012). Injecting blood rapidly produces a space-occupying he-
matoma (Bullock et al., 1984) whereas collagenase damages vessels
causing spontaneous bleeding over hours (MacLellan et al., 2008;
Rosenberg et al., 1990). These models differ in other ways, and
even with similar hematoma sizes, the collagenase model causes
substantially greater damage and functional deﬁcits (MacLellan et al.,
2008). Neither model perfectly reﬂects human ICH and so onemust de-
termine those aspects of ICH that each accurately models. Notably,
edema, a common endpoint in ICH animal research (MacLellan et al.,
2012), peaks after ~3 days and usually resolves within a week (Xi
et al., 1998). Whether spontaneous and treatment-related changes in
edema correlate with ICP is unknown in these models. Nonetheless,
reductions in edema, even modest ones, are typically used as evi-
dence of neuroprotection, in part as it is tacitly assumed to lessen ICP.
Furthermore, in some of these studies, unequivocal evidence of neuro-
protection, such as a reduction in lesion volume, is not provided.
Measuring ICP in rodents is limited to short monitoring times, inva-
sive approaches requiring anesthesia, and/or physical restraint or teth-
ering (Rooker et al., 2003; Zwienenberg et al., 1999). These problems
were circumvented in an ischemia model where telemetry was used
to measure epidural ICP in freely moving rats over several days (Silasi
et al., 2009). This approach is well suited to ICH models because it:
avoids causing cortical damage, does not require anesthesia that can
lower ICP and blood pressure (BP) (Albanese et al., 1997; Jiang andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ical impairments after ICH (Khatibi et al., 2011; Ma et al., 2009), and te-
lemetry does not require restraint or tethering.
Thus, we used telemetry in rats tomeasure ICP in the whole blood
and collagenase ICH models. Several experiments were conducted
to: evaluate the optimal location of monitoring, assess ICP and CPP
changes after severe ICH, compare ICP changes in the collagenase
and whole blood models, and correlate edema with ICP. We hypoth-
esized that higher ICP would follow more severe insults, which
would correlate with edema. We also expected higher ICP nearer
the site of injury than farther away.
Materials and methods
Animals
Fifty-four male Sprague Dawley rats (Biosciences, University of
Alberta, 350–500 g, ~3–5 months old) were on a standard 12 h
light–dark cycle with free access to food and water. Animals were
closely monitored and singly housed in polycarbonate cages. Subjects
were given soft food (rat chow, peanut butter dissolved and mixed in
distilled water with additional sunﬂower seeds) for 1–2 days after sur-
gery and regular rat chow thereafter (LabDiet 5001, St. Louis, MO). Ani-
mals were randomized, but due to obvious neurological impairments
(abnormal movements, turning bias, diminished contralateral limb use,
etc.) the investigator (C.H.) was not blinded to stroke assignment. How-
ever, data collection was computerized. The University of Alberta's Bio-
sciences Animal Care and Use Committee, which follow the Canadian
Council on Animal Care guidelines, approved all procedures.
Experiments
Experiment 1: location of ICP monitoring
Experiment 1 had 2 parts in which 8 animals were randomized to
severe ICH (0.3 U of collagenase) or sham surgery (SHAM) in each
part. ICP was recorded in the epidural space (ICH-E or SHAM-E) in
the ﬁrst and intraparenchymally (ICH-I or SHAM-I) in the second ex-
periment. ICP was recorded for 72 h and brain water content was
assessed at this time of presumed peak edema (Fingas et al., 2007;
Xi et al., 1998).
Experiment 2: stroke-induced CPP changes
Baseline heart rate (HR), body movement (arbitrary units), MAP,
systolic and diastolic pressure were recorded in 14 animals for 1
week before they were subjected to severe ICH (0.3 U of collagenase)
or SHAM surgery. These parameters were then measured and alter-
nated with ICP recordings every 6 h for 3 days and then every 12 h
for 4 days. Animals were euthanized 1 week after surgery to deter-
mine lesion volume.
Experiment 3: comparing ICP in different ICH models
Twenty-four rats were subjected to a SHAM procedure or a mod-
erate ICH induced by infusing 0.15 U of collagenase (ICH-CO) or
100 μL of whole blood (ICH-WB). Surgical procedures were mir-
rored according to the blood model to ensure consistency among
groups (e.g., surgical procedures and duration of anesthesia). ICP
was recorded until euthanasia at 72 h when water content was
assessed.
Surgery
For aseptic surgery, rats were anesthetized with isoﬂurane (4% in-
duction, 2% maintenance in 60% N2O and balance O2) while rectal tem-
perature was maintained at 37 °C. Surgical sites were shaved, treated
with 70% alcohol and dovidine (Laboratoire Atlas Inc., Montreal,
Canada) before cutting. Wounds were treated with bupivacaine(Hospira, Montreal, Canada). All telemetry probes were ﬁrst steril-
ized in 2% glutaraldehyde and rinsed several times in sterile saline.
BP monitoring
The PA-C10 (Data Sciences, St. Paul, MN) telemetry probes were
used to measure BP as well as ICP (below). For BP, the right femoral
artery was isolated and the PA-C10 catheter was inserted and se-
cured with sutures. The probe was secured subcutaneously and
the wound was treated with bupivacaine before it was sutured.
After implantation, rats were monitored by receivers (Model RPC-1)
placed under animal cages. Waveform data was averaged over 5 s
every minute. The data was then stored using Dataquest ART software
(v. 2.1). Due to signal interference, physiological parameters were
recorded from one probe per animal at a time and thus, simultaneous
recording from multiple probes in one animal was not possible
(DeBow and Colbourne, 2003).
ICH surgery
This surgery was performed as previously done (MacLellan et al.,
2008). Rats were placed in a stereotaxic frame and a hole was drilled
3.5 mm to the right and 0.07 mm posterior of Bregma avoiding the cor-
onal suture. A 26 G syringe (Hamilton, Reno, NV) was lowered 6.5 mm
from the skull surface into the striatum for infusion of: 1 μL of 0.3 U of
collagenase (severe ICH, type IV-S; Sigma, Oakville, Canada), 1 μL of
0.15 U of collagenase (moderate ICH), 1 μL of sterile saline, or 100 μL
of blood obtained from the tail vein. Injectionswere done over 5 (Exper-
iments 1 and 2) or 10 min (Experiment 3). An additional 5 (Experi-
ments 1 and 2) or 10 min (Experiment 3) elapsed before the needle
was removed to avoid drawback of liquid.
ICP implant
This apparatus was built similarly to our previous work (Silasi et al.,
2009). The shaft of a hollow nylon screw (C212SGN, PlasticsOne, Roa-
noke, VA) was cut to the thickness of a rat's skull. A 23 G needle shaft
(cannula), which was later inserted through the hollow screw, was
cut to ﬁt either in the epidural space or at 6.5 mm deep into the brain.
A ~2.5 cm long cylinder (5 cm3 syringe) was also made to protect the
ICP system from damage.
Immediately after collagenase, blood or saline infusion the
hollow screw was inserted into the burr hole and further secured
with Vetbond (3M Animal Care, St. Paul, MN). Two metal screws
were also inserted into the skull so that they would border the
inner lining of the plastic cylinder, which centered on the hollow
screw and sat vertically on the skull and was secured with dental
cement. The cannula was inserted into the nylon screw and se-
cured with Vetbond. The epidural or intraparenchymal cannula
was connected to the PA-C10 probe's catheter by a small length
of saline-ﬁlled PE20 tubing. All of this was placed inside the cyl-
inder and a rubber plunger tip sealed the apparatus. The incision
was sutured and animals were hydrated subcutaneously with
5 mL of sterile saline.
Pressure offsets were taken prior to and after probe use. As well,
the integrity of the ICP system was tested via an abdominal com-
pression maneuver before and after ICP monitoring (Silasi et al.,
2009).
Water content assessment
Rats were anesthetized with isoﬂurane and decapitated. The brain
was removed and blocked from 4 mm posterior to 2 mm anterior of
the infusion. This tissue was divided into ipsilateral and contralateral
cortical and striatal sections. The cerebellum served as a control. Brain
tissue was weighed before (wet weight) and after (dry weight) being
baked for 24 h at 100 °C (Fingas et al., 2007; Xi et al., 1998). The %
water content was calculated as ((wet weight − dry weight) / wet
weight) × 100.
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Animals were overdosed with pentobarbital (100 mg/kg i.p.) and
transcardially perfused with saline then 10% neutral buffered forma-
lin. Brains were post-ﬁxed and subsequently immersed in 10% su-
crose in formalin for 2 days before coronal sectioning at 40 μm.
Sections were taken every 200 μm from before, through and beyond
the injured zone and were stained with Cresyl Violet. Normally, total
tissue loss is calculated by subtracting the affected ipsilateral hemi-
sphere from the contralateral hemisphere. However, due to the se-
verity of ICH used in these experiments, hemispheric swelling was
expected on Day 7. Thus, total lesion volume (mm3) was quantiﬁed
for each animal (ImageJ v. 1.46, NIH) (MacLellan et al., 2008).
Statistics
Group sizes were based upon our methods paper that used a focal
ischemia model (Silasi et al., 2009). There were no signiﬁcant differ-
ences in ICP between the dark and light cycles so daily averages of
ICP were analyzed using repeated measures ANOVA with simple
contrasts when applicable (SPSS v. 17.0, Chicago, IL). The CPP, BP
and HR data were similarly analyzed. Signiﬁcant interactions were
analyzed using one-way ANOVAs on each day with post-hoc Tukey
tests. The last 3 days before ICH were averaged for baseline (BL)
values. Water content was evaluated with t-tests.
Lesion volumewas regressed with peak ICP (highest ICP averaged
over 1 h) and Day-3 water content with Day-3 ICP. Hours spent 1 or 2
standard deviations (SD) above the average SHAM values wereFig. 1. (A) Rat with two ICP (solid line) spikes at 16 h and 23 h, and death at ~24 h after collage
after 6 h. The activity readings are a relative measure of activity determined by the telemetry p
that diedwere excluded fromanalysis andwere not included in graphs B–D. (B) Severe ICH (0.3
intraparenchymal monitoring. (C) Hourly ICP readings are shown for the combined SHAM an
over time. Signiﬁcantly higher readings occurred in the ICH animals at almost all times. (D) W
ICH (*p ≤ 0.05).regressed (linear and quadratic) with water content (Experiments
1 and 3).Mortalitywas analyzed using a Fischer exact test. Comparisons
were signiﬁcant when p ≤ 0.05. All data are given as mean ± SD and
95% conﬁdence bands are plotted when applicable.
Results
Exclusions and mortality
Two animals in Experiment 1, 6 in Experiment 2, and 2 in Exper-
iment 3 were excluded due to technical difﬁculties, experimenter
error and mortality. Mortality occurred only after the 0.3 U collage-
nase infusion (severe ICH). In total, 15 animals had a severe ICH, 3
of which died within 24 h (p = 0.224 vs. SHAM). Two died quickly
after ICH. However, sufﬁcient ICP data was collected for 1 animal
(Fig. 1A), and this rat's data suggests that ICP values exceeding
25 mm Hg put animals at a high risk of spontaneous death. After ex-
clusions, Experiment 1 had 14 rats (ICH-E: n = 3, SHAM-E: n = 4,
ICH-I: n = 3, SHAM-I: n = 4), Experiment 2 had 8 rats (ICH: n = 5,
SHAM: n = 3), and Experiment 3 had 22 rats (ICH-CO: n = 8, ICH-
WB: n = 8, SHAM: n = 6).
Experiment 1: no difference between locations of ICP monitoring
Intraparenchymal and epidural data from Experiment 1, which used
the 0.3 U collagenase infusion, were analyzed in a 3-way ANOVA to as-
sess ICP monitoring location (Fig. 1B). There were no effects of Location,
Day× Location andDay× ICH× Location (p≥ 0.223). Thus, the epiduralnase induced ICH (0.3 U). This rat's activity (dashed line) was high initially but hypoactive
robe's movement across the receiver (detected by changes in signal strength). All animals
U) increased ICP for 3 days (daily averages). No differencewas found between epidural and
d combined ICH groups from Experiment 1 to illustrate group differences and variability
ater content in the ipsilateral and contralateral hemisphere increased 3 days after severe
Fig. 2. (A) Severe ICH (0.3 U of collagenase) increased ICP for 4 days (B) but did not alter
systolic or diastolic pressure orMAP. (C) CPPwas reduced onDays 1, 2 and 4 but not Day 3
after severe ICH (*p ≤ 0.05).
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were pooled for edema assessment. Additionally, epidural monitoring
was used for Experiments 2 and 3 to avoid injury from intraparenchymal
measurement. These epidural and intraparenchymal data from Ex-
periment 1 were also separately analyzed. ICP was greater in ICH-
E and ICH-I (p ≤ 0.008 vs. their SHAMs). There was no effect of
Day with intraparenchymal monitoring (p = 0.489), but there
was a Day effect with epidural monitoring (p = 0.050). There was
no ICH × Day effect for either experiment (p ≥ 0.074). Hourly aver-
ages (72 data points) are shown for the combined SHAM and the
combined ICH groups (Fig. 1C). A repeated-measured ANOVA on
these data revealed signiﬁcant Group, Time and Group × Time ef-
fects (p b 0.001) with further one-way ANOVAs showing signiﬁ-
cantly higher ICP readings in the ICH group for 68 of the 72 h with
most of these being p ≤ 0.001. Group variability was similar with
only one signiﬁcant Levene's test (for heterogeneity) out of 72
(hourly) comparisons.
Severe ICH substantially increased water content in the ipsilateral
striatum and cortex aswell asmodestly increasing edema in the contra-
lateral striatum and cortex (p≤ 0.014, Fig. 1D). The cerebellumwas not
different between ICH and SHAM (p = 0.899). In all cases, we visually
conﬁrmed that an ICH had occurred in collagenase treated rats, as ex-
pected with this model, and that there was no obvious bleed from the
SHAM procedure.
Experiment 2: severe ICH modestly reduced CPP
An unexplained increase in ICP (e.g., up to 26 mm Hg) occurred on
Days 6 and 7 in 2 of 3 SHAM rats (not shown) presumably from a tech-
nical problem (e.g., blocked cannula). Accordingly, this cast doubt on
the validity of these later readings and we conservatively omitted ICP
readings from Days 5 to 7. As in Experiment 1, severe ICH (0.3 U of col-
lagenase) increased ICP (p = 0.021) with no effect of Day (p = 0.150)
or Day × ICH (p = 0.092, Fig. 2A).
Severe ICH did not change diastolic, systolic or MAP (p ≥ 0.778,
Fig. 2B). For these, there was an effect of Day with slightly increasing
pressure after surgery (p≤ 0.001), and no signiﬁcantDay× ICH interac-
tion (p ≥ 0.298). Severe ICH reduced CPP (p = 0.014, Fig. 2C) with an
effect of Day (p ≤ 0.001) and no Day × ICH interaction (p = 0.674).
Thus, CPP was modestly reduced in ICH rats by 7.5 ± 1.32 mm Hg
each day.
There was no signiﬁcant effect of ICH on HR but it was slightly re-
duced after severe ICH by 6.7 BPM (p= 0.062, not shown). A Day ef-
fect was observed with an average reduction of 28.4 BPM ± 14.47
over the days (p ≤ 0.021 vs. BL), but there was no ICH × Day effect
(p = 0.630).
SHAM animals only had a needle track whereas all ICH rats had
substantial striatal injury with some cortical and corpus callosum
damage (Fig. 3A). There was no signiﬁcant linear (p = 0.101, r =
0.804, Fig. 3B) or quadratic relationship (p = 0.127, r = 0.934) be-
tween lesion volume (64.55 mm3 ± 21.47) and peak ICP. Similarly,
the relationships between average daily ICP and lesion size did not
reach statistical signiﬁcance (e.g., Day 1 average ICP with lesion
volume: p = 0.061, r = 0.861).
Experiment 3: increased ICP occurred in collagenase-induced ICH only
All of the ICH-CO (0.15 U collagenase dose) and ICH-WB (100 μL)
rats were visually conﬁrmed to have had an ICH on Day 3 (during
tissue processing), as expected for these models. Both ICH-CO and
ICH-WB increased water content in ipsilateral striatum and cortex
(p ≤ 0.010 vs. SHAM, Fig. 4A). However, ICH-CO had higher water
content than ICH-WB rats (p ≤ 0.003). The contralateral striatum
had increased water content in ICH-CO and ICH-WB (p ≤ 0.003),
which were not different (p = 0.931). There was also no difference
among groups in the cerebellum or contralateral cortex (p≥ 0.296).There was an effect of ICH, Day, and ICH × Day on ICP (p ≤ 0.023,
Fig. 4B). Increased ICP in the ICH-CO group occurred on Days 1
and 2 (p ≤ 0.023 vs. SHAM) but did not reach signiﬁcance on Day
3 (p = 0.157). The ICH-CO had higher ICP than ICH-WB on Days 2
and 3 (p ≤ 0.033) but not signiﬁcantly on Day 1 (p = 0.422). The
ICH-WB did not signiﬁcantly increase ICP (p= 0.848 vs. SHAM), al-
though there was a modest transient rise.
ICP predicts edema
Signiﬁcant linear (r = 0.625, p = 0.002, Fig. 5) and quadratic re-
lationships (r = 0.625, p = 0.009) were found between Day 3 water
content and Day 3 ICP in all ICH animals from Experiments 1 and 2.
Similarly, there was a signiﬁcant linear (r = 0.727, p ≤ 0.001) and
quadratic (r = 0.760, p ≤ 0.001) relationship between hours spent
1 SD above SHAM and Day 3 brain water content. The same held
for hours spent 2 SD above SHAM (not shown).
Discussion
We are the ﬁrst to show that telemetry can be used in freely mov-
ing rats to continually measure ICP for several days following ICH.
Our data thus conﬁrm the utility of this method for ICH. We found
that moderate (0.15 U) and severe (0.3 U) collagenase-induced
hemorrhaging elevated ICP for several days (same results in 4
Fig. 5. A signiﬁcant linear relationship exists between water content (ipsilateral striatum)
and ICP on Day 3 in all ICH animals (r = 0.625, p = 0.002).
Fig. 3. (A)A representative section (B&W imageof Cresyl violet stain) froma severe ICHon
Day 7 (0.3 U of collagenase). The solid black line deﬁnes the lesion that affected the stria-
tum, corpus callosum and cortex. (B) Therewas a non-signiﬁcant trend for peak ICP to lin-
early correlate with Day 7 lesion volume (p = 0.101, r = 0.804).
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severe collagenase insult also caused a small but signiﬁcant reduc-
tion in CPP. Overall, ICP predicted edema, which was present in all
models but greatest after the high collagenase dose. Finally, weFig. 4. (A) Day 3 brain water content after a moderate ICH induced by infusing 100 μL of
whole blood or 0.15 U of collagenase (*p≤ 0.05 vs. SHAM, #p≤ 0.05 vs. ICH-WB). (B) In-
creased ICP on Days 1 and 2 when ICH-CO was compared to SHAM, and on Days 2 and 3
when compared to ICH-WB. A signiﬁcant increase in ICP was not found when ICH-WB
was compared to SHAM (*p ≤ 0.05 among groups).observed similar ICP readings with epidural and intra-hematoma lo-
cations. Thus, at least for severe ICH in rat, monitoring location did
not matter as no pressure gradient was found.
Generally, our ﬁndings indicate that the collagenase model is
better suited to studying ICP/CPP changes than the standard model
of infusing 100 μL (or less) of blood. Furthermore, one might argue
that the modest amount of edema observed in many ICH studies, es-
pecially those using the whole blood model, likely has little impact
on ICP/CPP. The corollary of this is that reductions in edema in
these settings can have little to no meaningful impact on ICP/CPP.
Thus, neuroprotective treatments that improve behavior or lessen
injury in rodent studies are probably not working through edema re-
lated changes in ICP/CPP. Nonetheless, one would expect edema to
be a reasonable surrogate marker for other deleterious processes
(hematoma size, blood brain barrier damage, etc.), and thus changes
in edema may still be a useful measure of treatment efﬁcacy (e.g.,
functional outlook) in the short and perhaps long term. However,
the latter argument needs to be experimentally veriﬁed.
The higher ICP rise after a collagenase infusion likely stems from
the greater amount of edema present in the collagenase model and
probably not from a larger mass effect. Further work is needed to
prove this, but our previous study showed less intraparenchymal
blood after our moderate collagenase dose than what remained in
the brain after 100 μL of blood was infused (~85 μL at 12 h post-
ICH) (MacLellan et al., 2008). That study also showed greater blood
brain barrier injury and considerably more tissue destruction in the
collagenase model, which may account for the greater edema. Of
course infusing larger volumes of blood would cause greater ICP ele-
vation, but at least some of the additional blood would travel up the
needle track. A potential solution is to use the double injection
model, which may result in somewhat greater ICP. Notably, injecting
100 μL is already roughly like injecting twice the equivalent blood
volume than the average ICH in patients (Volpin et al., 1984). In-
stead, it is perhaps easier for an investigator to use larger doses of
collagenase to readily produce greater ICP elevations. Thus, by
using a severe-ICH collagenase model in rats, one could study ICP/CPP
therapies, such as hypothermia (Fingas et al., 2007; Kollmar et al.,
2010; MacLellan et al., 2006b; Staykov et al., 2013). Expectedly, mortal-
ity may be of concern with these severe insults.
One might use such arguments to favor one model. However, we
strongly encourage the use of multiple ICH models owing to other
important differences and because no one knows which model(s)
or endpoint(s) best predicts clinical ﬁndings (MacLellan et al.,
2012). Nonetheless, we are concerned about the common use of
edema as an efﬁcacy endpoint (stated or implied) in animal studies
(MacLellan et al., 2012). The current ﬁndings in rat show that even
very large hematomas causing considerable edema only modestly af-
fect ICP/CPP, which is unlikely to cause injury such as through induc-
ing peri-hematoma ischemia. As well, a number of therapies have
reduced edema without improving outcome (MacLellan et al.,
2006b). Thus, it seems that one should not rely solely upon edema
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edema may not necessarily reﬂect lack of neuroprotection.
Our telemetry method, like other approaches to measuring ICP, is
not perfect. First, pre-stroke ICP data were not collected because the
implant would have physically blocked the collagenase or blood in-
fusion. The delay in implanting the probe and for pressure to normal-
ize after opening the cranium (screw holes that were later sealed)
also means that we may have missed initial ICP changes. For exam-
ple, we would have expected a greater, but transient spike in ICP
after the 100-μL-blood infusion compared to the progressive bleed
caused by collagenase (MacLellan et al., 2008; Rosenberg et al.,
1990). Second, we were able to obtain clear data for at least 4 days,
but this is not enough to track the complete course of ICP changes
in all settings or animals. Further methodological reﬁnements or de-
layed probe implantation may circumvent this problem. Third, slight
errors created by head orientation, movements or other forms of
‘noise’ (e.g., electrical interference) cannot be easily excluded be-
yond that already done by the software and the present experimen-
tal design. Note that the placement of the probe on the head (sensor
at same ﬁxed level with respect to cannula tip) minimized errors,
such as would occur with rearing (Silasi et al., 2009). Regardless,
these minor errors are not expected to have biased our ﬁndings
(ICH vs. SHAM), which for the sham and severe collagenase rats
were reproducible across four separate experiments. Our ICP read-
ings in sham animals are also comparable to those previously
found in normal rats (Mandell and Zimmermann, 1980; Silasi et al.,
2009; Zwienenberg et al., 1999), but it is important to note that
there is considerable variability in resting ICP among rodent studies.
As well, we have previously shown that telemetry ﬁndings are com-
parable to a non-telemetry method in anesthetized rats (Silasi et al.,
2009) (Colbourne, unpublished data), at least in our hands. Regard-
less, different methods (e.g., placement of lead tip with respect to
the sensor) can certainly affect ICP readings thereby necessitating
the use of appropriate controls, as presently done (SHAMs), and an
evaluation of stroke-induced changes relative to those controls
(not just using raw values). Fourth, owing to signal interference we
were not able to measure ICP and BP simultaneously. It is possible
then that we missed some important moment-to-moment changes
in CPP.
Our experimental design also had some limitations. First, we did not
assess intracranial compliance in our ICH studies as we did not want to
inﬂuence edema or histological endpoints. Future studies could evalu-
ate changes in ICP with acute injections of cerebrospinal ﬂuid into the
contralateral ventricle. We would expect to see greater increases in
ICP in rats when brain compliance is compromised, perhaps such as
after severe ICH. Second, our results in rat will vary somewhat from
other species including humans owing to differences in amount (and
placement) of injury, edema, brain compliance, and of course the mea-
surement techniques used. Similarly, other factors, such as advanced
age (Gong et al., 2004; Kirkman et al., 2011; Wasserman et al., 2008),
must be considered. We used adult rats because they are most com-
monly used in ICH research (MacLellan et al., 2012), but further research
is clearly needed. Third, althoughwe did see that a hematomawas pres-
ent in all of our ICH rats, we did not quantify the volume of blood,which
would have been an interesting addition to ourwork. Additional studies
ormethodswould have been required to document both edemaandhe-
matoma size in the same animals. As well, earlier survival times would
be needed (e.g., 12–24 h) as hematoma size continuously declines with
time (i.e., hematoma resolution) thereby confounding the assessment
of hematoma size at 3 and especially our 7-day survival time. Hemato-
ma size is a key predictor of outlook in humans, and is expected to pre-
dict both edema and ICP in the ratmodels. However, as discussed above,
it is clearly not the only factor when comparing rodent models. Fourth,
we did not assess functional recovery because it is well known that rats
recover considerably in days following ICH (Hua et al., 2002; MacLellan
et al., 2006a) and we wished to avoid any unnecessary stressors fromhandling and testing, as well as the unavoidable loss of data with rats
being away from telemetry data recorders. Ofmany factors contributing
to impairment and recovery, our data suggests that edema and raised
ICP may be more important in the collagenase model we used than
the standard blood infusion model, but further work is needed to
prove this. Finally, we did not precisely determine the threshold for
mortality in our studies as this was not our intent, nor did we have
enough spontaneousmortality to precisely deﬁne that threshold. None-
theless, based upon our limited data here and in our previousworkwith
ischemic stroke (Silasi et al., 2009), it appears that those rats with ICP
values exceeding 25mmHg are at signiﬁcant risk of death, but of course
this will vary with the timing and duration of ICP changes as well as
model and animal characteristics.
In summary, the collagenase but not the blood infusion model
caused a signiﬁcant but modest rise in ICP lasting several days.
Thus, the collagenase model may be more appropriate for studying
therapies that target edema, such as hypothermia, and especially
its effects on ICP/CPP in rodents. Additional research is needed to fur-
ther explore the face validity of these models (e.g., aged hyperten-
sive rats) and to test therapies that inﬂuence ICP in an effort to
assess face validity that ultimately works towards improved transla-
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